Surrogate endpoints, part 1 from definition to meta-analytic framework /

Polni tekst
Series

Surrogate endpoints, part 2 further developments /

Polni tekst
Series

Randomization, blinding and drug supply in interactive voice response trials

Polni tekst
Series

Ecological considerations for gene drive systems

Polni tekst
Series

Guidance for responsible testing and implementation of gene-drive systems

Polni tekst
Series

Data fusion examples in fusing metabolomics and transcriptomics data /

Polni tekst
Series

Bridging our mandates evidence-based practice (EBP) and patient-centered care (PCC), part 1 of 2 /

Polni tekst
Series

Clinical research and care in the era of "N-of-1" precision cancer medicine

Polni tekst
Series

Bridging our mandates evidence-based practice (EBP) and patient-centered care (PCC), part 2 of 2/

Polni tekst
Series

Comparing transcriptomes of distant organisms the comparative ENCODE resource, part 1 of 2 /

Polni tekst
Series

Comparing transcriptomes of distant organisms models of gene expression, part 2 of 2 /

Polni tekst
Series

Survival analysis

Polni tekst
Series

Randomization in N-of-1 clinical trials is it possible to draw causal inferences from single-patient data /

Polni tekst
Series

Introduction to systematic reviews for librarians

Polni tekst
Series

Teixobactin kills pathogens without detectable resistance

Polni tekst
Series (Antibiotic resistance)
Series (Small molecule drug discovery)

Manufacturing viral gene therapy vectors general approaches and challenges /

Polni tekst
Series

Clinical proteomics in gastrointestinal cancers

Polni tekst
Series

A concept for multi-marker approaches in clinical proteomics

Polni tekst
Series

Proteomics in cardiovascular disease clinical considerations /

Polni tekst
Series

Application of proteomics in fetal and neonatal medicine

Polni tekst
Series